5-Bromo-2,4-di-tert-butoxypyrimidine

Catalog No. :
ACRWDP843
CAS No. :
19752-61-5
Molecular Formula :
C12H19BrN2O2
Molecular Weight :
303.20

IUPAC Name:5-bromo-2,4-di-tert-butoxypyrimidine

5-Bromo-2,4-di-tert-butoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$111.00Login to see priceIn stockIn stock
25g95%$402.00Login to see priceIn stockIn stock
100g95%$1366.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2,4-di-tert-butoxypyrimidine
IUPAC Name5-bromo-2,4-di-tert-butoxypyrimidine
MDL No.MFCD01927527
Molecular FormulaC12H19BrN2O2
Molecular Weight303.20
SMILESCC(C)(C)OC1=NC(OC(C)(C)C)=C(Br)C=N1
InChI KeyMAWUVEDTRZARNC-UHFFFAOYSA-N
Synonym5-bromo-2,4-di-tert-butoxypyrimidine | 19752-61-5 | 5-Bromo-2,4-di(tert-butoxy)pyrimidine | 5-bromo-2,4-bis[(2-methylpropan-2-yl)oxy]pyrimidine | 2,4-DI-(TERT-BUTOXY)-5-BROMOPYRIMIDINE | 5-Bromo-2,4-di-(tert-butoxy)pyrimidine | Pyrimidine, 5-bromo-2,4-bis(1,1-dimethy
CAS No.19752-61-5
PubChem CID818851

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRWDP843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRWDP843 route product structure diagram
    ACRWDP84319752-61-5 In Stock
Inquiry

2. ACRWDP843 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRWDP843 route product structure diagram
    ACRWDP84319752-61-5 In Stock
Inquiry

Comments (0)